[PDF] Top 20 Perspectivas de estudiantes montenses sobre la política
Has 10000 "Perspectivas de estudiantes montenses sobre la política" found on our website. Below are the top 20 most common "Perspectivas de estudiantes montenses sobre la política".
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
... In particular, it has been demonstrated that IL-23 produced by DCs and keratinocytes can induce IL-17A production by Th17 cells, Tc17 cells, γδ T cells, and innate cell subsets (mast cells and neutrophils). Furthermore, ... See full document
24
Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
... Brodalumab, a human antiinterleukin-17 receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: efficacy and safety results from a phase 2 random[r] ... See full document
5
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
... with moderate-to-severe plaque ...period, treatment maintenance, best supportive care (BSC), and ...maintenance therapy, whereas non-responders transitioned to ...maintenance ... See full document
39
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
... Abstract: Plaque psoriasis is an immune-mediated skin disease that affects roughly 3% of adults in the United ...of psoriasis have led to the development of targeted biologic therapies for ... See full document
11
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
... chronic moderate-to-severe plaque psoriasis of at least 6 months, psoriasis involving at least 10% BSA, a PASI score of at least 12, and a static Physician’s Global Assessment (sPGA) ... See full document
5
Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece
... patients were classified as either responders or nonre- sponders depending on whether or not they achieved the minimum improvement criterion for PP, namely the Psoriasis Area and Severity Index (PASI) criterion. ... See full document
12
Treating pediatric plaque psoriasis: challenges and solutions
... Inverse psoriasis is a variant of plaque psoriasis that spares the extensor surface typically affected by psoriasis vulgaris and affects the intertriginous areas with minimal or no scal- ... See full document
5
Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol
... of psoriasis on the patients’ quality of life was measured using the PDI questionnaire about daily ...of treatment as good (47%) than in the dithranol group ... See full document
23
Psoriasis in children
... Pediatric psoriasis has numerous challenges: it presents with age-specific clinical characteristics, and the presentation may evolve with ...Many treatment options approved for adults have not been studied ... See full document
42
<p>Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review</p>
... with moderate-to-severe psoriasis (sPGA ≥ 3, PASI score ≥ 12 and >10% ...12-week treatment period (induction) was followed by a 40-week open-label period during which patients who had been ... See full document
5
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
... The use of a single cytokine as a potential target of antipsoriatic treatment has been widely validated with the success of the anti-TNF a ...of psoriasis, other master cytokines with therapeutic ... See full document
16
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
... to possible adverse effects were not entered into the model but were only considered when sensitivity analyses were performed and costs were varied. The hypothesis was that their impact would be relatively small but this ... See full document
8
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
... the use of etanercept as a comparator group is poor given the alternatives avail- able including adalimumab and ustekinumab which are the current gold standard treatments for ... See full document
6
Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis
... Itolizumab therapy was less compared to placebo group (arm A, ...Itolizumab therapy, and a single case of septic arthritis occurred in a patient 3 months after the last dose of ...erythrodermic ... See full document
6
<p>Therapeutic drug monitoring of biologics in psoriasis</p>
... the treatment of moderate to severe ...of psoriasis, its impact on patients’ lives and costs spent on therapy motivate an evidence-based and cost-effective utility of ...(secukinumab, ... See full document
5
Infliximab Therapy in Iraqi Patients with Moderate to Severe Psoriasis
... Psoriasis Area and Severity Index (PASI) score was calculated according to dermnet [8]. Body Surface Area (BSA) was calculated as the patient’s hand, including the palm, fingers and thumb represent roughly 1% of ... See full document
199
Itch in psoriasis: epidemiology, clinical aspects and treatment options
... with moderate to severe chronic-plaque psoriasis selected consecutively from the patients visiting the Department of Dermatology of the University of ...involved psoriasis and pruritus, ... See full document
15
Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
... from ixekizumab again demonstrate higher PASI 75 than these three biologics at the most efficacious dosing ...Additionally, ixekizumab also achieves higher sPGA 0-1 than both tildrakizumab and ustekinumab ... See full document
5
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
... Abstract: Psoriasis is a common chronic immune-mediated skin disease, with systemic involve- ment and significant impact in patients’ quality of ...higher Psoriasis Area Severity Index (PASI) 75, PASI 90, ... See full document
5
Evaluating practice patterns for managing moderate to severe plaque psoriasis
... self-reported psoriasis, of which 514 qualified to complete the ...of psoriasis in all provinces except ...their psoriasis was managed by ...conditions, treatment for high blood pressure was ... See full document
25
Related subjects